Federal Agency

  High drug prices are in the news. In some cases, such as AIDS-treating Daraprim and the life-saving EpiPen, the price increases dramati¬≠cally. In other cases, which have received less attention, the price stays high longer than it should. Either way, anticompetitive behavior often lurks behind inflated prices. By delaying price-reducing generic competition, this behavior […]

Introduction Policymakers and administrators periodically revise or jettison rules, enforcement priorities, and agency structures for a variety of reasons, from resource constraints to changes in administration. This is particularly the case when presidential administrations change, as evidenced, for example, by the transition from President Carter to President Reagan. As the current U.S. presidency undergoes one […]